✦ LIBER ✦

Interferon beta-1a treatment reduces incidence of multiple sclerosis when initiated during first demyelinating event

✍ Scribed by VONRAISON, F

Book ID: 122908508
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 373 KB
Volume: 5
Category: Article
ISSN: 1462-9410
DOI: 10.1016/S1462-9410(01)90428-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intramuscular Interferon Beta-1A Therapy

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

✍ Jacobs, Lawrence D.; Beck, Roy W.; Simon, Jack H.; Kinkel, R. Phillip; Brownsche 📂 Article 📅 2000 🏛 Massachusetts Medical Society 🌐 English ⚖ 162 KB

Effect of early interferon beta-1a thera

Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event

✍ H. Pakdaman; M. A. Sahraian; A. Fallah; R. Pakdaman; K. Ghareghozli; M. Ghafarpo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

OPL068 Recombinant interferon beta or gl

OPL068 Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Dose titration of intramuscular interfer

Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation

✍ Matson, Mark A.; Zimmerman, Thomas R.; Tuccillo, Dianne; Tang, Yongqiang; Deykin 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 486 KB

Cost-Effectiveness Analysis of Interfero

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis

✍ John P. Caloyeras; Bin Zhang; Cheng Wang; Marianne Eriksson; Sten Fredrikson; Ka 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 882 KB

Comparison of two dosing frequencies of

Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

✍ Giancarlo Comi; Nicola De Stefano; Mark S Freedman; Frederik Barkhof; Chris H Po 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 224 KB